{"output": [["bluebird bio, Inc.", "ORG", "Announce", "issued additional shares", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Operate_In", "Cambridge, Massachusetts", "GPE"], ["bluebird bio, Inc.", "ORG", "Control", "Lenti-D", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Control", "LentiGlobin", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Participates_In", "gene therapy clinical programs", "CONCEPT"], ["bluebird bio, Inc.", "ORG", "Participates_In", "oncology pipeline", "CONCEPT"], ["bluebird bio, Inc.", "ORG", "Collaborates_With", "Celgene", "ORG"], ["Goldman Sachs & Co. LLC", "ORG", "Act_As", "joint book-running managers", "ORG"], ["BofA Merrill Lynch", "ORG", "Act_As", "joint book-running managers", "ORG"], ["J.P. Morgan Securities LLC", "ORG", "Act_As", "joint book-running managers", "ORG"], ["Cowen", "ORG", "Act_As", "joint book-running managers", "ORG"], ["bluebird bio, Inc.", "ORG", "Has", "automatically effective shelf registration statement", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Has", "prospectus supplement", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Has", "accompanying prospectus", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Has", "Securities and Exchange Commission", "ORG/REG"], ["bluebird bio, Inc.", "ORG", "Issues", "shares of common stock", "PRODUCT"], ["bluebird bio, Inc.", "ORG", "Raise", "gross proceeds of approximately $51.3 million", "ECON_INDICATOR"]], "published": "2018-01-09T00:05:00.000+02:00"}